Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.63 |
| ▸ | RARB | P10826 | 8/20 | 0.55 |
| ▸ | RARA | P10276 | 2/20 | 0.55 |
| ▸ | RARG | P13631 | 1/20 | 0.55 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.51 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.51 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MTOR | P42345 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | GCGR | P47871 | 1/20 | 0.46 |
| ▸ | LPL | P06858 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7786181 | 0.98 | TAAR1 (0.61) | TAAR1RARBRARARARGCYP17A1 | |
| SCHEMBL28632619 | 0.95 | TAAR1 (0.65) | TAAR1RARBRARARARGCYP17A1 | |
| SCHEMBL502723 | 0.90 | TAAR1 (0.56) | TAAR1RARBRARARARGCYP17A1 | |
| SCHEMBL3172512 | 0.90 | TAAR1 (0.51) | TAAR1RARBRARARARGCYP17A1 | |
| SCHEMBL3158297 | 0.88 | TAAR1 (0.50) | TAAR1RARBRARARARGCYP17A1 | |
| SCHEMBL3172767 | 0.88 | TAAR1 (0.50) | TAAR1RARBRARARARGCYP17A1 | |
| SCHEMBL502700 | 0.88 | TAAR1 (0.69) | TAAR1CYP17A1CYP3A4CYP11B1CYP11B2 | |
| SCHEMBL3159318 | 0.88 | TAAR1 (0.49) | TAAR1RARBRARARARGCYP17A1 | |
| SCHEMBL3158490 | 0.86 | TAAR1 (0.48) | TAAR1RARBRARARARGCYP17A1 | |
| SCHEMBL3168333 | 0.86 | TAAR1 (0.48) | TAAR1RARBRARARARGCYP17A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118307575-B | Synthesis method of 4' -alkyl-3-fluoro-4-biphenylboronic acid | 山东盛华电子新材料有限公司 | 2024-08-02 | — | — | CN | claimed |
| CN-118307575-A | Synthesis method of 4' -alkyl-3-fluoro-4-biphenylboronic acid | 山东盛华电子新材料有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-118307575-B | Synthesis method of 4' -alkyl-3-fluoro-4-biphenylboronic acid | 山东盛华电子新材料有限公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-118307575-A | Synthesis method of 4' -alkyl-3-fluoro-4-biphenylboronic acid | 山东盛华电子新材料有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-106132915-A | Method for producing compound having oxydifluoromethylene skeleton | 大金工业株式会社 | 2016-11-16 | — | — | CN | disclosed |
| EP-2116522-B1 | PENTACYCLIC LIQUID CRYSTAL COMPOUND HAVING CF<SB>2</SB>O BONDING GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | JNC CORP (JP) | 2013-09-18 | — | — | EP | disclosed |
| US-7951433-B2 | Five-ring liquid crystal compound having CF2O bonding group, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| US-7951433-B2 | Five-ring liquid crystal compound having CF2O bonding group, liquid crystal composition, and liquid crystal display device | CHISSO CORPORATION (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20100127211-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND HAVING CF20 BONDING GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2010-05-27 | — | — | US | disclosed |
| US-20100127211-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND HAVING CF20 BONDING GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2010-05-27 | — | — | US | disclosed |
| EP-2116522-A1 | PENTACYCLIC LIQUID CRYSTAL COMPOUND HAVING CF<SB>2</SB>O BONDING GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY | Chisso Corporation (JP) | 2009-11-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100127211-A1 | FIVE-RING LIQUID CRYSTAL COMPOUND HAVING CF20 BONDING GROUP, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CFAP20, KIF20A, KIF20B | TAAR1 3234/4885RARB 2364/4885RARA 1623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.